Frontlight ResearchEarly access
CompletedNo phase
Pulsed Electromagnetic Field (PEMF) Therapy in Thumb CMC Arthritis
Key facts
- Who runs it
- Stanford University
- Where
- Redwood City, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 61 people enrolled
- Started
- 20 Jun 2023
- Ended
- 31 Aug 2024
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- PEMF device
- Sham PEMF device
- Record updated
- 3 August 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (10)Hide the full registry criteria
Who can take part
- an existing diagnosis of CMC OA by a hand specialist based on clinically (tenderness to palpation at the CMC joint and/or positive CMC grind test) and/or radiographically identified CMC OA
- reported pain intensity during activities of daily living less than 7 on the Numeric Pain Rating Scale (NPRS)
Who cannot take part
- have had prior fracture, significant hand injury, tenosynovitis, complex regional pain syndrome, and/or Dupuytren's disease affecting the thumb
- have hand or wrist implants
- with current infection in hand or upper extremity
- history of surgical or procedural intervention for CMC OA in the hand of study interest
- have heart or brain implants
- pregnant
- unable to consent
- do not speak English
Where in United States
- Stanford Medicine Outpatient CenterRedwood City, United States
About the trial
What the trial wants to find out
Long-Term Objective: Determine if high-frequency PEMF therapy reduces pain in patients with thumb carpometacarpal (CMC) joint osteoarthritis (OA).
Read full original descriptionShow less
Study Design and Methods: This will be a randomized controlled pilot study with 60 subjects with CMC OA randomly divided in two groups. Thirty subjects will receive high-frequency PEMF therapy overlying the CMC joint overnight daily for four weeks. The other 30 subjects will receive a sham PEMF therapy device applied to the same joint overnight daily for four weeks. Pain and function questionnaires will be obtained for all patients at enrollment, four weeks, and six weeks.
The 2 groups in the trial
- PEMF deviceTreatment being tested
- Sham PEMF deviceSham treatment, for comparison
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 3 August 2025